It is concluded that EAM-2201 has the probable to cause in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and is particularly evaluated in pooled human liver microsomes. The computed data are as opposed While using the offered to start with basic principle calculations and https://hermannf173aqf8.wikifrontier.com/user